MoneyAM MoneyAM
 Home   Log In   Register   Our Services   My Account   Contact   Help 
 Stockwatch   Level 2   Portfolio   Charts   Research   Share Price   Awards   Indices   Market Scan   Company Zone   Traders' Room 
 Funds   Trades   Terminal   Alerts   Heatmaps   News   Stock Screener   Forward Diary   Forex Prices   Director Deals   Investors' Room 
 CFDs   Shares   SIPPs   ISAs   Forex   ETFs   Videos   Comparison Tables   Spread Betting   Broker Notes   Shares Magazine 
You are NOT currently logged in

Filter Criteria [Hide filter]
Epic: Keywords: 
From: Time:  (hh:mm) RNS:  MonAM: 
To: Time:  (hh:mm)
Please Note - Streaming News is only available to subscribers to the Active Level and above
Too much news? Try filtering with NewsWatch. Alternatively, try our Desktop News Alert.

The following articles are from the past month only. Click here for older news.
 
Next
19/06/25 10:06 Syncona Limited (SYNC) Syncona plans asset realisation strategy as net asset value falls ALN
15/05/25 13:42 Syncona Limited (SYNC) IN BRIEF: Syncona investee Spur reports ‘encouraging’ drug trial data ALN
07/05/25 11:02 Syncona Limited (SYNC) Syncona’s Beacon Therapeutics receives positive data for XLRP therapy ALN
06/02/25 11:19 Syncona Limited (SYNC) Syncona sees negative nine-month return despite quarterly rise ALN
05/02/25 11:28 Syncona Limited (SYNC) Syncona investee Achilles plans liquidation and capital return ALN
27/12/24 09:11 Syncona Limited (SYNC) Syncona investee sells assets to AstraZeneca for $12 million ALN
06/12/24 14:55 Syncona Limited (SYNC) Syncona hails positive trial data for new Beacon Therapeutics drug ALN
14/11/24 12:28 Syncona Limited (SYNC) Syncona net assets values down; announces new portfolio firm Slingshot ALN
11/11/24 10:28 Syncona Limited (SYNC) Syncona’s Autolus wins FDA approval for aggressive leukaemia therapy ALN
23/10/24 09:37 Syncona Limited (SYNC) Syncona celebrates investee’s positive trial data on Gaucher disease ALN
09/10/24 08:56 Syncona Limited (SYNC) Syncona makes further investment in Purespring Therapeutics ALN
03/10/24 11:48 Syncona Limited (SYNC) Syncona makes further investment in Resolution Therapeutics ALN
20/09/24 10:58 Syncona Limited (SYNC) Syncona’s Beacon Therapeutics presents trial results at conference ALN
19/09/24 14:11 Syncona Limited (SYNC) Syncona notes investee Achilles’ plan to close its lead program ALN
13/08/24 09:59 Syncona Limited (SYNC) Syncona net asset value down 5% reflecting fall in Autolus share price ALN
03/07/24 11:07 Syncona Limited (SYNC) Syncona’s portfolio Beacon Therapeutics raises $170 million ALN
25/06/24 12:56 Syncona Limited (SYNC) IN BRIEF: Syncona Chair & CEO Hollowood buys £100,000 in shares ALN
20/06/24 10:22 Syncona Limited (SYNC) Syncona swings to annual profit despite challenging market conditions ALN
17/06/24 13:15 Syncona Limited (SYNC) Syncona to invest £40 million into newly created Spur Therapeutics ALN
17/05/24 14:34 Syncona Limited (SYNC) Syncona notes Autolus’s first quarter loss widens amid higher costs ALN
09/05/24 13:58 Syncona Limited (SYNC) IN BRIEF: Syncona’s Freeline gets positive results for Gaucher disease ALN
11/04/24 14:22 Syncona Limited (SYNC) Syncona agrees to sell stake in investee company for £7.4 million ALN
04/04/24 17:06 Syncona Limited (SYNC) IN BRIEF: Syncona notes investee Achilles’s annual loss narrows ALN
14/03/24 14:16 Syncona Limited (SYNC) Syncona portfolio company Autolus posts widened loss for 2023 ALN
12/02/24 18:01 Syncona Limited (SYNC) IN BRIEF: Freeline shareholders approve Syncona acquisition ALN
08/02/24 13:45 Syncona Limited (SYNC) UPDATE: Syncona portfolio strengthens thanks to Autolus ALN
08/02/24 09:41 Syncona Limited (SYNC) Syncona portfolio strengthens in third quarter thanks to Autolus ALN
22/01/24 12:19 Syncona Limited (SYNC) IN BRIEF: Syncona notes FDA acceptance of Autolus’s BLA for obe-cel ALN
19/01/24 08:36 Syncona Limited (SYNC) Syncona says Freeline trial for Gaucher disease treatment positive ALN
04/12/23 09:37 Syncona Limited (SYNC) IN BRIEF: Syncona notes Beacon’s ‘encouraging’ AGTC-501 trial data ALN
22/11/23 14:30 Syncona Limited (SYNC) IN BRIEF: Syncona agrees to buyout deal with Freeline Therapeutics ALN
16/11/23 10:34 Syncona Limited (SYNC) Syncona reports declining asset value as investment head steps down ALN
14/11/23 11:29 Syncona Limited (SYNC) IN BRIEF: Syncona notes investee company’s quarterly loss ALN
03/11/23 11:51 Syncona Limited (SYNC) TRADING UPDATES: Augmentum Fintech makes further investment in Tide ALN
18/10/23 12:01 Syncona Limited (SYNC) IN BRIEF: Syncona announces takeover offer for Freeline Therapeutics ALN
04/10/23 14:28 Syncona Limited (SYNC) Syncona says Freeline and SwanBio clinical trails make progress ALN
29/09/23 09:51 Syncona Limited (SYNC) IN BRIEF: Syncona launches £40 million share buyback programme ALN
11/09/23 09:51 Syncona Limited (SYNC) Syncona suffers negative valuation hit as Novartis discontinues GT005 ALN
15/08/23 13:56 Syncona Limited (SYNC) IN BRIEF: Syncona notes clinical progress of portfolio firm Freeline ALN
10/08/23 09:33 Syncona Limited (SYNC) IN BRIEF: Syncona says net asset value slips 1% in first quarter ALN
04/08/23 14:09 Syncona Limited (SYNC) IN BRIEF: Syncona’s portfolio Achilles Therapeutics net loss narrows ALN
15/06/23 08:44 Syncona Limited (SYNC) Syncona net asset value falls as cites economic uncertainty, inflation ALN
12/06/23 08:44 Syncona Limited (SYNC) Syncona launches new gene therapy company with £96 million funding ALN
30/05/23 14:30 Syncona Limited (SYNC) IN BRIEF: Syncona investee Freeline swings to first-quarter profit ALN
10/05/23 16:33 Syncona Limited (SYNC) Syncona say portfolio clinical company Achilles have widened losses ALN
04/04/23 19:29 Syncona Limited (SYNC) IN BRIEF: Syncona leads £22.5 million financing in Mosaic ALN
07/02/23 09:45 Syncona Limited (SYNC) Syncona net asset value falls on ‘challenging’ market, dollar weakness ALN
09/12/22 10:36 Syncona Limited (SYNC) Syncona portfolio firm hits 70% remission rate goal in leukaemia trial ALN
06/12/22 12:00 Syncona Limited (SYNC) Syncona investee Achilles continues to progress cancer trials ALN
01/12/22 10:16 Syncona Limited (SYNC) Syncona’s Achilles says cancer treatment shows promise; seals buy ALN
Next